KYOWA KIRIN CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public, Subsidiary
- Established
- 1949-07-01
- Employees
- 5.9K
- Market Cap
- -
- Website
- http://www.kyowa-kirin.co.jp
A Study of OPC-262 in Patients With Type 2 Diabetes
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2014-01-08
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT01046318
A Study of OPC-262 in Patients With Type 2 Diabetes
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-10-19
- Last Posted Date
- 2014-01-08
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 255
- Registration Number
- NCT00997282
Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease
Completed
- Conditions
- First Posted Date
- 2009-10-15
- Last Posted Date
- 2012-08-23
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 8020
- Registration Number
- NCT00995163
Study of KRN951 in Patients With Solid Tumors
- First Posted Date
- 2009-09-02
- Last Posted Date
- 2017-01-05
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT00970411
Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients
- First Posted Date
- 2009-08-12
- Last Posted Date
- 2012-08-31
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 308
- Registration Number
- NCT00957203
Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease
- First Posted Date
- 2009-08-10
- Last Posted Date
- 2017-03-15
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 58
- Registration Number
- NCT00955318
Study of KW-6002 (Istradefylline) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
- First Posted Date
- 2009-08-10
- Last Posted Date
- 2012-08-29
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 373
- Registration Number
- NCT00955526
A Study of KW-3357 in Congenital Antithrombin Deficiency
- First Posted Date
- 2009-07-13
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT00938288
- Locations
- 🇩🇪
Department of Haemotogy, Haemastasy, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
🇸🇪Center for Thrombosis and Haemostasis, Malmo University Hospital, Malmö, Sweden
🇸🇪Dept Obst Gyn/Section for Women and Child Health/Clinical Trial Unit, Karolinska University Hospital, Stockholm, Sweden
Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor
- First Posted Date
- 2009-06-16
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 13
- Registration Number
- NCT00921336
- Locations
- 🇺🇸
Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸University of Maryland Greenbaum Cancer Center, Baltimore, Maryland, United States
🇺🇸Memorial Sloan Kettering, New York, New York, United States
Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma
- First Posted Date
- 2009-06-15
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT00920790
© Copyright 2024. All Rights Reserved by MedPath